Review



moderate e2  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress moderate e2
    Moderate E2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 170 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/moderate e2/product/MedChemExpress
    Average 96 stars, based on 170 article reviews
    moderate e2 - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    96
    MedChemExpress moderate e2
    Moderate E2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/moderate e2/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    moderate e2 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    94
    Shanghai Korain Biotech Co Ltd e2 elisa kit
    E2 Elisa Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2 elisa kit/product/Shanghai Korain Biotech Co Ltd
    Average 94 stars, based on 1 article reviews
    e2 elisa kit - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    MedChemExpress estradiol e2
    Estradiol E2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/estradiol e2/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    estradiol e2 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    94
    Valiant Co Ltd e2
    E2, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2/product/Valiant Co Ltd
    Average 94 stars, based on 1 article reviews
    e2 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    MedChemExpress e2
    Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM <t>E2,</t> E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain
    E2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    e2 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress e2 31
    Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM <t>E2,</t> E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain
    E2 31, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2 31/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    e2 31 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    93
    Valiant Co Ltd mp biomedicals 07m4975a
    Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM <t>E2,</t> E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain
    Mp Biomedicals 07m4975a, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mp biomedicals 07m4975a/product/Valiant Co Ltd
    Average 93 stars, based on 1 article reviews
    mp biomedicals 07m4975a - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Valiant Co Ltd 07m4975a
    Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM <t>E2,</t> E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain
    07m4975a, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/07m4975a/product/Valiant Co Ltd
    Average 93 stars, based on 1 article reviews
    07m4975a - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Valiant Co Ltd 17β estradiol e2
    Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM <t>E2,</t> E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain
    17β Estradiol E2, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/17β estradiol e2/product/Valiant Co Ltd
    Average 93 stars, based on 1 article reviews
    17β estradiol e2 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM E2, E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain

    Journal: Journal of Neuroinflammation

    Article Title: Estrogen receptor 1 activation suppresses microglia-derived Tnf-α signaling as a photoreceptor self-protection mechanism

    doi: 10.1186/s12974-025-03669-z

    Figure Lengend Snippet: Esr1 as an intrinsic self-protective mechanism. A GSEA of RNA-seq data from rd10 retinas at postnatal day 21 (P21) revealed significant positive enrichment of Estrogen-related pathways. B - C Immunofluorescence staining for Esr1 (green) demonstrated increased signal intensity in the entire retina of rd10 mice compared to congenic wt controls and negative staining controls. Esr1 was predominantly localized to IS, INL, and GCL. Negative control rd10 P21: n = 3; wt P21: 3; rd10 P21: 3. D - E Co-immunostaining of Iba1 (red) and Esr1 (green) further confirmed Esr1 expression in reactive microglia. Panel ( D ) shows 20 × confocal imaging, revealing widespread Iba1 microglia exhibiting overlapping Esr1 immunoreactivity. Panel ( E ) shows high-resolution 63 × imaging, demonstrating clear colocalization of Iba1 and Esr1 at the single-cell level, with both markers displaying shared positive signal within individual microglial somata and processes. F - G TUNEL staining (magenta) of ex vivo rd1 retinal explants showed that treatment with 10 µM E2, E2 + 10 nM Esr1 antagonist AZD9496, or 15 nM Esr1 agonist PPT markedly reduced ONL TUNEL positivity compared with untreated rd1 explants, consistent with the quantification in ( H ). Untr. wt: 3; Untr. rd1: 12; E2 rd1: 6; E2 + AZD9496 rd1: 4; PPT rd1: 4. H - I TUNEL staining and quantification of ex vivo rd10 retinal explants under identical treatment conditions revealed that E2 increased ONL TUNEL positivity, and E2 combined with the Esr1 antagonist AZD9496 further exacerbated photoreceptor cell death. In contrast, PPT treatment markedly reduced ONL cell death. J - K In vivo single intravitreal injection of PPT from P16-P23 significantly decreased ONL TUNEL positivity in rd10 mice. Untr. rd10: 13; PPT rd10: 13. L - M The same treatment improved dark-adapted ERG a-wave amplitudes, indicating partial functional rescue of photoreceptor responses. Scatter plots depict the percentage of positive cells in the ONL or the total fluorescence intensity; each dot corresponds to one independent retinal sample. Error bars: SD; significance levels: ns = p > 0.05; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer; scale bar = 50 µm. Dashed lines indicate untreated mutant or wt baseline levels. DAPI (grey) was used as nuclear counterstain

    Article Snippet: After 48 h in culture, explants were treated with 10 μM E2 [ ] (HY-B0141; MedChemExpress, Sollentuna, Sweden), 10 μM E2 plus 10 nM AZD9496 [ ] (HY-12870; MedChemExpress), 15 nM PPT [ ] (HY-100689; MedChemExpress), 0.63 nM Etanercept [ ] (ETN, HY-108847; MedChemExpress), 6.7 μM Infliximab [ ] (IFX, HY-P9970; MedChemExpress), 65 μM R7050 [ ] (HY-110203; MedChemExpress), or 4 μM AZD8797 [ ] (HY-13848; MedChemExpress).

    Techniques: RNA Sequencing, Immunofluorescence, Staining, Negative Staining, Negative Control, Immunostaining, Expressing, Imaging, TUNEL Assay, Ex Vivo, In Vivo, Injection, Functional Assay, Fluorescence, Mutagenesis